withdrawal

Documents about withdrawal

• Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome#1369361ClinicalTrials.gov
• Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)#1057551ClinicalTrials.gov
• Lithium Cannabis Withdrawal Study#1259998ClinicalTrials.gov
• Treating Alcohol Withdrawal With Oral Baclofen#1112324ClinicalTrials.gov
• Outpatient Treatment of Alcohol Withdrawal Syndrome#1073719ClinicalTrials.gov
• The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS)#967925ClinicalTrials.gov
• Phenobarbital for Acute Alcohol Withdrawal#863055ClinicalTrials.gov
• Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19#1352692ClinicalTrials.gov
• A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic Pain#1362134ClinicalTrials.gov
• Assessment of Energetic Resonance by Cutaneous Stimulation on Withdrawal Alcohol Symptoms.#1138529ClinicalTrials.gov
• Osteopathic Treatment to Alcohol Withdrawal Syndrome#803774ClinicalTrials.gov
• Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse#981546ClinicalTrials.gov
• Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients#1352773ClinicalTrials.gov
• The Effects of Caffeine Withdrawal on Migraine#869765ClinicalTrials.gov
• Pregabalin for Opiate Withdrawal Syndrome#1112421ClinicalTrials.gov
• Opioid Withdrawal Symptoms in Critically Ill Patients#1262891ClinicalTrials.gov
• Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis#1094218ClinicalTrials.gov
• Treatment of Alcohol Withdrawal in Hospital Patients#1214593ClinicalTrials.gov
• Treatment of Polydrug-Using Opiate Dependents During Withdrawal#1363401ClinicalTrials.gov
• Ketamine vs. Placebo as Adjunctive Therapies for Severe Alcohol Withdrawal#208312ClinicalTrials.gov
• Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal#1057818ClinicalTrials.gov
• Neurostimulation for Opiate Withdrawal in the PICU#869234ClinicalTrials.gov
• Evaluation of the Electronic Cigarette Withdrawal Syndrome#1059061ClinicalTrials.gov
• Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)#1280919ClinicalTrials.gov
• Withdrawal Exposure With Withdrawal Regulation Training for Smoking Cessation#874936ClinicalTrials.gov
• Oral Cannabidiol for Opioid Withdrawal#1295517ClinicalTrials.gov
• The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program#873539ClinicalTrials.gov
• CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome#1372453ClinicalTrials.gov
• Faculty Senate Resolution 79-14#489211LSU Digital Commons
• Faculty Senate Resolution 81-05#489225LSU Digital Commons
• Evaluating Buspirone to Treat Opioid Withdrawal#810811ClinicalTrials.gov
• Development of an Opioid Withdrawal Clinical Outcome Assessment#841650ClinicalTrials.gov
• Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal#860880ClinicalTrials.gov
• Effect of PP-01 on Cannabis Withdrawal Syndrome#871044ClinicalTrials.gov
• A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal#872149ClinicalTrials.gov
• Qualitative Understanding of Experiences With the SIMPLIFY Trial#893912ClinicalTrials.gov
• Randomized Withdrawal Study in Patients With Schizophrenia#915362ClinicalTrials.gov
• Assessing a Clinically-meaningful Opioid Withdrawal Phenotype#1245505ClinicalTrials.gov
• Suppression, Dissociation, and Withdrawal: An Integrative Model of Addiction Maintenance#1391701OSF
• Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients with Chronic Myeloid Leukemia#899215ClinicalTrials.gov
• A Pharmacokinetic, Safety, and Tolerability Study of LUCEMYRA in the Treatment of Opioid Withdrawal Management in Adolescent Subjects#1174290ClinicalTrials.gov
• Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS)#844133ClinicalTrials.gov
• Comparing the Treatment of Alcohol Withdrawal Syndrome Using Gabapentin Versus Lorazepam#1231431ClinicalTrials.gov
• Effective Withdrawal Time and Adenoma Detection Rate#1058934ClinicalTrials.gov
• The Effect of Music Therapy on Newborns#1072994ClinicalTrials.gov
• Use of SVS Device to Improve Outcomes for Neonatal Opioid Withdrawal Syndrome.#1089001ClinicalTrials.gov
• Protocolized Initiation of Clonidine to Prevent Dexmedetomidine Withdrawal#1320741ClinicalTrials.gov
• Effects of Buspirone in Opiate Withdrawal#1375651ClinicalTrials.gov
• Cannabidiol (CBD) for the Treatment of Alcohol Withdrawal#1394694ClinicalTrials.gov
• Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal#1362642ClinicalTrials.gov

Related topics